Literature DB >> 23144170

TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice.

Maria Pihlgren1, Alberto B Silva, Rime Madani, Valérie Giriens, Ying Waeckerle-Men, Antonia Fettelschoss, David T Hickman, María Pilar López-Deber, Dorin Mlaki Ndao, Marija Vukicevic, Anna Lucia Buccarello, Valérie Gafner, Nathalie Chuard, Pedro Reis, Kasia Piorkowska, Andrea Pfeifer, Thomas M Kündig, Andreas Muhs, Pål Johansen.   

Abstract

Immunoglobulin class switching from IgM to IgG in response to peptides is generally T cell-dependent and vaccination in T cell-deficient individuals is inefficient. We show that a vaccine consisting of a dense array of peptides on liposomes induced peptide-specific IgG responses totally independent of T-cell help. Independency was confirmed in mice lacking T cells and in mice deficient for MHC class II, CD40L, and CD28. The IgG titers were high, long-lived, and comparable with titers obtained in wild-type animals, and the antibody response was associated with germinal center formation, expression of activation-induced cytidine deaminase, and affinity maturation. The T cell-independent (TI) IgG response was strictly dependent on ligation of TLR4 receptors on B cells, and concomitant TLR4 and cognate B-cell receptor stimulation was required on a single-cell level. Surprisingly, the IgG class switch was mediated by TIR-domain-containing adapter inducing interferon-β (TRIF), but not by MyD88. This study demonstrates that peptides can induce TI isotype switching when antigen and TLR ligand are assembled and appropriately presented directly to B lymphocytes. A TI vaccine could enable efficient prophylactic and therapeutic vaccination of patients with T-cell deficiencies and find application in diseases where induction of T-cell responses contraindicates vaccination, for example, in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23144170     DOI: 10.1182/blood-2012-02-413831

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Nanoparticulate STING agonists are potent lymph node-targeted vaccine adjuvants.

Authors:  Melissa C Hanson; Monica P Crespo; Wuhbet Abraham; Kelly D Moynihan; Gregory L Szeto; Stephanie H Chen; Mariane B Melo; Stefanie Mueller; Darrell J Irvine
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

Review 2.  Surface engineering for lymphocyte programming.

Authors:  Elana Ben-Akiva; Randall A Meyer; David R Wilson; Jordan J Green
Journal:  Adv Drug Deliv Rev       Date:  2017-05-10       Impact factor: 15.470

3.  Activation of TRIF-dependent and independent immune responses by neisserial heat shock protein complex vaccines.

Authors:  Garrett Z Ng; Jia-Xi Han; Camilo A Colaco; Philip Sutton
Journal:  Hum Vaccin Immunother       Date:  2016-06-20       Impact factor: 3.452

4.  Dissociation of TRIF bias and adjuvanticity.

Authors:  Katharina Richard; Darren J Perkins; Erin M Harberts; Yang Song; Archana Gopalakrishnan; Kari Ann Shirey; Wendy Lai; Alexandra Vlk; Anup Mahurkar; Shreeram Nallar; Lynn D Hawkins; Robert K Ernst; Stefanie N Vogel
Journal:  Vaccine       Date:  2020-05-07       Impact factor: 3.641

5.  Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.

Authors:  Suttipun Sungsuwan; Zhaojun Yin; Xuefei Huang
Journal:  ACS Appl Mater Interfaces       Date:  2015-08-03       Impact factor: 9.229

6.  Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial.

Authors:  Michael S Rafii; Olivier Sol; William C Mobley; Saskia Delpretti; Brian G Skotko; Anna D Burke; Marwan N Sabbagh; Shauna H Yuan; Robert A Rissman; Margaret Pulsifer; Casey Evans; A Carol Evans; Gregory Beth; Nicolas Fournier; Julian A Gray; Antonio Melo Dos Santos; Valerie Hliva; Marija Vukicevic; Marie Kosco-Vilbois; Johannes Streffer; Andrea Pfeifer; Howard H Feldman
Journal:  JAMA Neurol       Date:  2022-06-01       Impact factor: 29.907

Review 7.  Enhancing vaccine effectiveness with delivery technology.

Authors:  Marie Beitelshees; Yi Li; Blaine A Pfeifer
Journal:  Curr Opin Biotechnol       Date:  2016-03-06       Impact factor: 9.740

8.  TRIF signaling is essential for TLR4-driven IgE class switching.

Authors:  Erin Janssen; Esra Ozcan; Kyriaki Liadaki; Haifa H Jabara; John Manis; Sumana Ullas; Shizuo Akira; Katherine A Fitzgerald; Douglas T Golenbock; Raif S Geha
Journal:  J Immunol       Date:  2014-02-14       Impact factor: 5.422

9.  Functionalization of cobalt porphyrin-phospholipid bilayers with his-tagged ligands and antigens.

Authors:  Shuai Shao; Jumin Geng; Hyun Ah Yi; Shobhit Gogia; Sriram Neelamegham; Amy Jacobs; Jonathan F Lovell
Journal:  Nat Chem       Date:  2015-04-20       Impact factor: 24.427

10.  Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy.

Authors:  Clara Theunis; Natalia Crespo-Biel; Valérie Gafner; Maria Pihlgren; María Pilar López-Deber; Pedro Reis; David T Hickman; Oskar Adolfsson; Nathalie Chuard; Dorin Mlaki Ndao; Peter Borghgraef; Herman Devijver; Fred Van Leuven; Andrea Pfeifer; Andreas Muhs
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.